Tag: Urinary Tract Infections
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
Medication approved for uUTIs in women and pediatric patients aged 12 years and older
Bladder Wall Thickness Reflects Severity of Bladder Inflammatory Conditions
Findings in patients with interstitial cystitis/bladder pain syndrome can help with diagnosis of interstitial cystitis subtypes
Low-Frequency Bladder Vibration Beneficial for UTI in Spinal Cord Injury
Four weeks after LFBV, intervention group had significantly lower urinary leukocytes, postvoid residual volume, fewer signs and symptoms of UTI
Nitrofurantoin, Cranberry Products May Cut UTI Episodes in Children
Review shows lower odds of symptomatic UTI episodes in children with history of recurrent UTIs with nitrofurantoin, cranberry
ASN: Recurrent UTIs Impact eGFR in Children With Vesicoureteral Reflux
Recurrent urinary tract infections linked to decrease of up to 27 mL/min/1.73 m² in estimated glomerular filtration rate
FDA Approves New Antibiotic for Uncomplicated Urinary Tract Infections
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis, and S. saprophyticus
Computer Prompts Could Reduce Empiric Antibiotic Use for UTI
17.4 percent reduction seen in empiric extended-spectrum days of therapy, with no increase in safety outcomes
Cefepime-Taniborbactam Superior to Meropenem for Complicated UTI
Cefepime-taniborbactam superior for composite success, which included microbiologic and clinical success
Incidence of Pediatric UTI Decreased in Early Pandemic Period
UTI incidence decreased compared with prepandemic trends, but all measures of UTI severity decreased or remained stable
Improvement Needed in Managing UTI in Patients With Neurogenic Bladder
Providers who are not knowledgeable about neurogenic bladder or who communicate ineffectively are part of the problem
